Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells

A Corrigendum to this article was published on 07 February 2013

Abstract

Cerebral aneurysm (CA) rupture is one of the leading causes of stroke death. Recent experimental studies suggest that the pathophysiology of CA is closely associated with inflammation. A transcription factor, Ets-1, has been shown to regulate vascular inflammation and remodeling in a physiological and pathological condition. The expression and role of Ets-1 in CA development has been investigated in this study. Ets-1 was expressed and activated mainly in vascular smooth muscle cells (VSMCs) in both experimentally induced rat CAs and human CA walls by immunohistochemistry, western blotting and enzyme-linked mobility shift assay. The downstream target of Ets-1 in CA development was identified by chromatin immunoprecipitation (CHIP) analysis. CHIP analysis revealed that Ets-1 transactivated monocyte chemoattractant protein-1 (MCP-1) expression in CA walls. Treatment with ets decoy oligodeoxynucleotides resulted in the prevention of CA enlargement, upregulation of MCP-1 expression and increase in macrophage accumulation in CA walls. In conclusion, Ets-1 mediates MCP-1 expression in VSMCs in CA walls, thus promoting the progression of CAs. Inhibition of DNA-binding activity of Ets-1 may lead to the prevention of human CA enlargement and rupture. Results of this study will provide us a clue to a novel therapeutic strategy for CAs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. van Gijn J, Kerr RS, Rinkel GJ . Subarachnoid haemorrhage. Lancet 2007; 369: 306–318.

    Article  Google Scholar 

  2. Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K, Moriwaki T et al. NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation 2007; 116: 2830–2840.

    Article  CAS  Google Scholar 

  3. Chyatte D, Bruno G, Desai S, Todor DR . Inflammation and intracranial aneurysms. Neurosurgery 1999; 45: 1137–1146.

    Article  CAS  Google Scholar 

  4. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N . Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke 2009; 40: 942–951.

    Article  CAS  Google Scholar 

  5. Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N . Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 2007; 38: 162–169.

    Article  CAS  Google Scholar 

  6. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N . Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. Stroke 2008; 39: 2603–2610.

    Article  CAS  Google Scholar 

  7. Oettgen P . Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 2006; 99: 1159–1166.

    Article  CAS  Google Scholar 

  8. Jayaraman T, Berenstein V, Li X, Mayer J, Silane M, Shin YS et al. Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery 2005; 57: 558–564.

    Article  Google Scholar 

  9. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R . Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke 1999; 30: 1396–1401.

    Article  CAS  Google Scholar 

  10. Tulamo R, Frosen J, Junnikkala S, Paetau A, Pitkaniemi J, Kangasniemi M et al. Complement activation associates with saccular cerebral artery aneurysm wall degeneration and rupture. Neurosurgery 2006; 59: 1069–1076.

    Article  Google Scholar 

  11. Hashiya N, Jo N, Aoki M, Matsumoto K, Nakamura T, Sato Y et al. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 2004; 109: 3035–3041.

    Article  CAS  Google Scholar 

  12. Kavurma MM, Bobryshev Y, Khachigian LM . Ets-1 positively regulates Fas ligand transcription via cooperative interactions with Sp1. J Biol Chem 2002; 277: 36244–36252.

    Article  CAS  Google Scholar 

  13. Hultgardh-Nilsson A, Cercek B, Wang JW, Naito S, Lovdahl C, Sharifi B et al. Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ Res 1996; 78: 589–595.

    Article  CAS  Google Scholar 

  14. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J . Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 1997; 17: 490–497.

    Article  CAS  Google Scholar 

  15. Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC et al. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005; 115: 2508–2516.

    Article  CAS  Google Scholar 

  16. Santiago FS, Khachigian LM . Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1. Circ Res 2004; 95: 479–487.

    Article  CAS  Google Scholar 

  17. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N . Gene expression profile of the intima and media of experimentally induced cerebral aneurysms in rats by laser-microdissection and microarray techniques. Int J Mol Med 2008; 22: 595–603.

    CAS  PubMed  Google Scholar 

  18. Kadirvel R, Ding YH, Dai D, Lewis DA, Raghavakaimal S, Cloft HJ et al. Gene expression profiling of experimental saccular aneurysms using deoxyribonucleic acid microarrays. AJNR Am J Neuroradiol 2008; 29: 1566–1569.

    Article  CAS  Google Scholar 

  19. Aoki T, Nishimura M, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N . Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(−/−) mice. Lab Invest 2009; 89: 730–741.

    Article  CAS  Google Scholar 

  20. Miyake T, Aoki M, Masaki H, Kawasaki T, Oishi M, Kataoka K et al. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model. Circ Res 2007; 101: 1175–1184.

    Article  CAS  Google Scholar 

  21. Takaoka A, Taniguchi T . Cytosolic DNA recognition for triggering innate immune responses. Adv Drug Deliv Rev 2008; 60: 847–857.

    Article  CAS  Google Scholar 

  22. Takeshita F, Gursel I, Ishii KJ, Suzuki K, Gursel M, Klinman DM . Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin Immunol 2004; 16: 17–22.

    Article  CAS  Google Scholar 

  23. Aoki T, Nishimura M, Ishibashi R, Kataoka H, Takagi Y, Hashimoto N . Toll-like receptor 4 expression during cerebral aneurysm formation. J Neurosurg 2009 (in press).

  24. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448: 501–505.

    Article  CAS  Google Scholar 

  25. Wang Z, Choi MK, Ban T, Yanai H, Negishi H, Lu Y et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci USA 2008; 105: 5477–5482.

    Article  CAS  Google Scholar 

  26. Nagata I, Handa H, Hashimoto N, Hazama F . Experimentally induced cerebral aneurysms in rats: Part VI. Hypertension. Surg Neurol 1980; 14: 477–479.

    CAS  PubMed  Google Scholar 

  27. Aoki T, Kataoka H, Moriwaki T, Nozaki K, Hashimoto N . Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms. Stroke 2007; 38: 2337–2345.

    Article  CAS  Google Scholar 

  28. Miwa K, Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M et al. Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Gene Ther 2005; 12: 1109–1118.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Grants-in-Aid for Scientific Research (number 20791008 and 19890112) from the Ministry of Education, Science and Culture of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Kataoka.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aoki, T., Kataoka, H., Nishimura, M. et al. Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells. Gene Ther 17, 1117–1123 (2010). https://doi.org/10.1038/gt.2010.60

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2010.60

Keywords

This article is cited by

Search

Quick links